Plastic Surgery Doctors in Shreveport, LA Accepting Medicare

5 Plastic Surgery doctors found. Showing 1 - 5

Marjorie R Chelly, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 Kings Hwy, Shreveport, LA 71103 Phone: 318-675-5000    Fax: 318-675-5666

Dr. Wallace Harold Brown Ii, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2210 Line Ave, Suite 204, Shreveport, LA 71104 Phone: 318-221-9671    Fax: 318-425-2343

Dr. Barron Johns O'neal, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2210 Line Ave, Suite 204, Shreveport, LA 71104 Phone: 318-221-9671    Fax: 318-425-2343

Dr. Ronzee Mcintyre Bridges, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4300 Youree Dr, Suite 300, Shreveport, LA 71105 Phone: 318-219-8555    Fax: 318-219-8557

Sergei Kalsow, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Surgery, Shreveport, LA 71103 Phone: 318-675-6111    Fax: 318-675-6141

News Archive

Infants with genetic epilepsy show better response to treatment with ketogenic diet

Infants and young children with epilepsy due to a confirmed genetic abnormality had a better response to treatment with ketogenic diet compared to patients with other types of epilepsy, according to a review of 10-year experience at Ann & Robert H. Lurie Children's Hospital of Chicago. Results were published in Scientific Reports.

Furiex Pharmaceuticals enrolls patient for Phase III clinical trial of eluxadoline for treatment of diarrhea

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.

Park Nicollet, HealthPartners complete merger

HealthPartners and Park Nicollet Health Services today announced the completion of their agreement to combine their organizations. Effective today, the two organizations are officially joined under the name HealthPartners and a single, consumer-governed board of directors.

Research may point to more effective therapeutic targets for prion diseases

Scientists from The Scripps Research Institute have determined for the first time that prions, bits of infectious protein devoid of DNA or RNA that can cause fatal neurodegenerative disease, are capable of Darwinian evolution.

Cross- province initiatives to address uncertainity of small, rural, northern health care

The Ontario Health Coalition in partnership with dozens of community groups in rural and northern Ontario, are announcing a series of cross- province activities. This group initiative is a direct response to the uncertain future of small, rural and northern health care, as a result of hospital restructuring.

Read more Medical News

› Verified 8 days ago